News Main Page

Email A Friend

More News

January 15, 2026
California Division of Workers' Compensation posts reminder for submission of Annual Report of Inventory for claims reported during calendar year 2025

January 13, 2026
Division of Workers' Compensation now accepting applications for Qualified Medical Evaluator (QME) exam on April 11-17

January 13, 2026
Wildfires, Storms, Floods hit record high in insured losses

January 7, 2026
California Division of Workers' Compensation announces release of Requests for Proposal to modernize EAMS

The Division of Workers’ Compensation (DWC) Pharmacy and Therapeutics (P&T) Committee meeting is scheduled for Wednesday, January 21, 2026, from 12:30 p.m. to 2:30 p.m. P&T Committee members will attend the meeting remotely on a virtual internet platform that may also be accessed by the public. In addition, DWC will host a physical location for members of the public who may wish to access the virtual meeting in person at the Oakland state building.

The meeting is open to the public and can be accessed remotely or in-person.
 
• The video conference meeting can be joined at the P&T Meeting Link or via telephone at 1 (619) 407-9860, phone conference ID: 415 994 871#; Passcode: EJ6Bs9JE

• The meeting can be joined in person at the Elihu Harris State Building, 1515 Clay Street, Room #11 (2nd Floor), Oakland, CA 94612

*****
advertisement

Workers' compensation defense attorney sought -- California

*****

The Pharmacy and Therapeutics Committee is established pursuant to Labor Code section 5307.29 as an advisory body to consult with the DWC Administrative Director on updates to the Medical Treatment Utilization Schedule (MTUS) drug formulary. Government Code section 11123.5 authorizes public meetings of advisory bodies to be conducted virtually through December 31, 2025, and requires the agency to provide a physical meeting location where members of the public may physically attend, observe, hear and participate in the video/audio online meeting.

The meeting agenda and related materials are posted on the DWC P&T Committee webpage. DWC welcomes comment from the public on the formulary drug list. All correspondence should be directed to Formulary@dir.ca.gov.

from the DWC Newsline issued and then edited for publication on adjustercom by editor Lonce Lamonte, lonce@adjustercom.com